WO2002038185A3 - Injectable sustained release delivery system with loperamide - Google Patents

Injectable sustained release delivery system with loperamide Download PDF

Info

Publication number
WO2002038185A3
WO2002038185A3 PCT/US2001/047116 US0147116W WO0238185A3 WO 2002038185 A3 WO2002038185 A3 WO 2002038185A3 US 0147116 W US0147116 W US 0147116W WO 0238185 A3 WO0238185 A3 WO 0238185A3
Authority
WO
WIPO (PCT)
Prior art keywords
loperamide
delivery system
sustained release
release delivery
injectable sustained
Prior art date
Application number
PCT/US2001/047116
Other languages
French (fr)
Other versions
WO2002038185A2 (en
Inventor
Richard L Dunn
David W Osborne
Original Assignee
Atrix Lab Inc
Richard L Dunn
David W Osborne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrix Lab Inc, Richard L Dunn, David W Osborne filed Critical Atrix Lab Inc
Priority to AU2002226000A priority Critical patent/AU2002226000A1/en
Publication of WO2002038185A2 publication Critical patent/WO2002038185A2/en
Publication of WO2002038185A3 publication Critical patent/WO2002038185A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides for a flowable composition suitable for use as a controlled release implant, a method for forming a flowable composition for use as a controlled release implant, and methods for using the flowable composition. The composition comprises a biodegradable thermoplastic polyester that is at least substantially insoluble in aqueous medium or body fluid; a biocompatible organic solvent that is miscible to dispersible in aqueous medium or body fluid and can effectively dissolve the thermoplastic polyester; and an antihyperalgesic opiate.
PCT/US2001/047116 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide WO2002038185A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002226000A AU2002226000A1 (en) 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71082500A 2000-11-13 2000-11-13
US09/710,825 2000-11-13

Publications (2)

Publication Number Publication Date
WO2002038185A2 WO2002038185A2 (en) 2002-05-16
WO2002038185A3 true WO2002038185A3 (en) 2003-01-16

Family

ID=24855703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047116 WO2002038185A2 (en) 2000-11-13 2001-11-13 Injectable sustained release delivery system with loperamide

Country Status (2)

Country Link
AU (1) AU2002226000A1 (en)
WO (1) WO2002038185A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133968B2 (en) 2006-06-29 2012-03-13 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039729A1 (en) * 2002-06-25 2005-03-09 Alza Corp SHORT-TERM DEPOSIT FORMULATIONS
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1539101B1 (en) * 2002-07-31 2009-01-07 ALZA Corporation Injectable multimodal polymer depot compositions and uses thereof
US7368126B2 (en) 2002-11-06 2008-05-06 Guohua Chen Controlled release depot formulations
US7202259B2 (en) 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
CN1822816A (en) * 2003-05-30 2006-08-23 阿尔萨公司 Implantable elastomeric depot compositions and uses thereof
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
AU2006314730B2 (en) 2005-11-21 2011-02-03 Purdue Pharma L.P. 4-Oxadiazolyl-piperidine compounds and use thereof
DK2079485T3 (en) 2006-11-01 2012-08-06 Purdue Pharma Lp PHENYLPROPIONAMIDE COMPOUNDS AND THE USE THEREOF
MX354603B (en) 2007-05-25 2018-03-13 Indivior Uk Ltd Sustained delivery formulations of risperidone compounds.
WO2009148580A2 (en) * 2008-06-03 2009-12-10 Qlt Usa, Inc. Controlled release copolymer formulation with improved release kinetics
US10350159B2 (en) 2010-05-31 2019-07-16 Laboratories Farmacéuticos Rovi, S.A. Paliperidone implant formulation
US10335366B2 (en) 2010-05-31 2019-07-02 Laboratorios Farmacéuticos Rovi, S.A. Risperidone or paliperidone implant formulation
US10285936B2 (en) 2010-05-31 2019-05-14 Laboratorios Farmacéuticos Rovi, S.A. Injectable composition with aromatase inhibitor
PL2394663T3 (en) 2010-05-31 2022-02-21 Laboratorios Farmaceuticos Rovi, S.A. Compositions for injectable in-situ biodegradable implants
US10881605B2 (en) 2010-05-31 2021-01-05 Laboratorios Farmaceuticos Rovi, S.A. Methods for the preparation of injectable depot compositions
US10463607B2 (en) 2010-05-31 2019-11-05 Laboratorios Farmaceutics Rofi S.A. Antipsychotic Injectable Depot Composition
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
AU2019348739A1 (en) * 2018-09-25 2021-04-22 Tolmar International, Ltd. Liquid polymer delivery system for extended administration of drugs
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
TW202313047A (en) 2021-09-21 2023-04-01 西班牙商禾霏藥品實驗室有限公司 Antipsychotic injectable depot composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018940A1 (en) * 1990-06-04 1991-12-12 Nova Pharmaceutical Corporation Branched polyanhydrides
WO2000024374A1 (en) * 1998-10-28 2000-05-04 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
WO2001035929A2 (en) * 1999-11-16 2001-05-25 Atrix Laboratories, Inc. Biodegradable polymer composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018940A1 (en) * 1990-06-04 1991-12-12 Nova Pharmaceutical Corporation Branched polyanhydrides
WO2000024374A1 (en) * 1998-10-28 2000-05-04 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
WO2001035929A2 (en) * 1999-11-16 2001-05-25 Atrix Laboratories, Inc. Biodegradable polymer composition

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133968B2 (en) 2006-06-29 2012-03-13 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8940315B2 (en) 2008-04-18 2015-01-27 Medtronic, Inc. Benzodiazepine formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier

Also Published As

Publication number Publication date
WO2002038185A2 (en) 2002-05-16
AU2002226000A1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
WO2002038185A3 (en) Injectable sustained release delivery system with loperamide
WO2002000173A3 (en) Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells
IS6794A (en) Levprolide polymer dispersions with improved efficiency
EP1479707A3 (en) Biodegradable polyesters and method for their preparation
EP1125577A3 (en) Liquid drug delivery compositions
DE69721481D1 (en) DELAYED RELEASE ACTIVE SUBSTANCE FORMULATIONS
AU4477001A (en) Injectable sustained release pharmaceutical composition and processes for preparing the same
ATE409023T1 (en) SUSTAINED RELEASE DRUG DELIVERY SYSTEMS, USE AND METHOD FOR PRODUCING THE SAME
WO1998000183A3 (en) Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
WO2004043432A3 (en) Controlled release depot formulations
EP2363102A3 (en) Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
WO2007106457A3 (en) Fluidic tissue augmentation compositions and methods
WO2008041245A3 (en) Injectable depot composition and it's process of preparation
WO2006121968A3 (en) Method for treatment of uterine fibroid tumors
WO2004101007A3 (en) Method of freshening air
AU2001238384A1 (en) Delivery systems using preformed biodegradable polymer compositions and methods
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
ATE261316T1 (en) INJECTABLE POLYMER COMPOSITION FOR PRODUCING AN IN SITU IMPLANT
BR0005413B1 (en) process for preparing a porous, biodegradable and biocompatible polymeric platform for tissue engineering.
ZA200204374B (en) Pre-filled syringe and method for making same.
AU2001232161A1 (en) System and method for creating, distributing and managing artificial agents
AU3550100A (en) Biodegradable, injectable oligomer-polymer composition
DE60018469D1 (en) POLYMER, METHOD FOR THE PRODUCTION THEREOF, AND SOLUBLE WATER- AND OIL-REPELLING COMPOSITIONS CONTAINING THIS POLYMER
Peters Artificial recharge and water supply in the Netherlands, state of the art and future trends
WO2002060508A8 (en) Biodegradable porous scaffold material

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP